TCT 2022: SYMPLICITY HTN-3 trial data show sustained long-term blood pressure reductions with Medtronic renal denervation procedure Medical Device Investing
Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies Pharmaceutical Investing
Applied UV's Airocide® and Lumicide Address CDC's Recommendation for Handling Environments Contaminated by Monkeypox Medical Device Investing
Danaher Announces Intention to Separate Environmental & Applied Solutions Segment to Create an Independent, Publicly Traded Company Medical Device Investing
Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations Pharmaceutical Investing
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Medtronic To Contact Him Directly To Discuss Their Options Medical Device Investing
